Geometric systematic prostate biopsy.

Objective:The common sextant prostate biopsy schema lacks a three-dimensional (3D) geometric definition. The study objective was to determine the influence of the geometric distribution of the cores on the detection probability of prostate cancer (PCa). Methods:The detection probability of significa...

Descripción completa

Detalles Bibliográficos
Publicado en:Minimally Invasive Therapy & Allied Technologies Vol. 26; no. 2; pp. 78 - 86
Autores principales: Chang, Doyoung, Chong, Xue, Kim, Chunwoo, Jun, Changhan, Petrisor, Doru, Han, Misop, Stoianovici, Dan
Formato: equations & formulas pictorial research tables/charts Journal Article
Publicado: Taylor & Francis Ltd Apr2017
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Objective:The common sextant prostate biopsy schema lacks a three-dimensional (3D) geometric definition. The study objective was to determine the influence of the geometric distribution of the cores on the detection probability of prostate cancer (PCa). Methods:The detection probability of significant (>0.5 cm3) and insignificant (<0.2 cm3) tumors was quantified based on a novel 3D capsule model of the biopsy sample. The geometric distribution of the cores was optimized to maximize the probability of detecting significant cancer for various prostate sizes (20–100cm3), number of biopsy cores (6–40 cores) and biopsy core lengths (14–40 mm) for transrectal and transperineal biopsies. Results:The detection of significant cancer can be improved by geometric optimization. With the current sextant biopsy, up to 20% of tumors may be missed at biopsy in a 20 cm3prostate due to the schema. Higher number and longer biopsy cores are required to sample with an equal detection probability in larger prostates. Higher number of cores increases both significant and insignificant tumor detection probability, but predominantly increases the detection of insignificant tumors. Conclusion:The study demonstrates mathematically that the geometric biopsy schema plays an important clinical role, and that increasing the number of biopsy cores is not necessarily helpful.ABSTRACT FROM PUBLISHERCopyright of Minimally Invasive Therapy & Allied Technologies is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.